Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study

Objective Studies examining coprescription and dosages of mood stabilizers (MSs) with antipsychotics for psychotic disorders are infrequent. Based on sparse extant data and clinical experience, we hypothesized that adjunctive MS use would be associated with certain demographic (e.g., younger age), c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Human psychopharmacology 2020-11, Vol.35 (6), p.1-7
Hauptverfasser:	Lim, Wai Kwong, Chew, Qian Hui, He, Yan‐Ling, Si, Tian‐Mei, Chiu, Fung‐Kum Helen, Xiang, Yu‐Tao, Kato, Takahiro A., Kanba, Shigenobu, Shinfuku, Naotaka, Lee, Min‐Soo, Park, Seon‐Cheol, Park, Yong‐Chon, Chong, Mian‐Yoon, Lin, Shih‐Ku, Yang, Shu‐Yu, Tripathi, Adarsh, Avasthi, Ajit, Grover, Sandeep, Kallivayalil, Roy Abraham, Udomratn, Pichet, Chee, Kok Yoon, Tanra, Andi J., Rabbani, Md Golam, Javed, Afzal, Kathiarachchi, Samudra, Waas, Dulshika, Myint, Wing Aung, Sartorius, Norman, Tran, Van Cuong, Nguyen, Kim Viet, Tan, Chay‐Hoon, Baldessarini, Ross J., Sim, Kang
Format:	Artikel
Sprache:	eng
Schlagworte:	adjunctive treatment Antipsychotics Asia Body mass index Dosage Epidemiology Lithium Mental disorders Mood mood stabilizers Patients Psychosis Psychotropic drugs Remission Schizophrenia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!